- FORTH at a glance
- Central Administration
- Crete University Press
- Science & Technology Park of Crete
- FORTH Internal Committees
- PRAXI Network
- Liaison Office
- Researchers - Personnel
- The Disk of Phaistos
- Institute of Electronic Structure & Laser
- Institute of Molecular Biology & Biotechnology
- Institute of Computer Science
- Institute of Applied and Computational Mathematics
- Institute for Mediterranean Studies
- Institute of Chemical Engineering Sciences
- Institute of Astrophysics
- Institute of Petroleum Research
News > Press Releases
Page 2 of 4
Select YearAll | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
European scientists receive funding from Seventh EU Framework Programme to develop novel therapies for inflammation-associated cancer.
Jun 11, 2009A network of scientists led by the Foundation of Research & Technology - Hellas (FORTH), Greece, have been awarded a grant from the European Commission Seventh Framework Program, aiming to increase our understanding of how chronic inflammation in the body can lead to cancer. It is anticipated that this research program, code-named INFLA-CARE, for Inflammation and Cancer Research in Europe, will also lead to the development of novel approaches for the treatment and improved management of inflammation-associated malignancies, such as liver and colon cancer.
Apr 27, 2009TECHNART 2009 is co-organized by the Institute of Nuclear Physics at NCSR "Demokritos" and IESL-FORTH and its goal to provide a scientific forum to present and promote the use of analytical spectroscopy techniques in the field of Cultural Heritage.
Book presentation-event: "Brain & Neuroscience"
Feb 16, 2009Crete University Press (CUP) invites you to a book presentation-event: "Brain & Neuroscience" on Wednesday February 18, 2009 at 19hrs.
FORTH Photonics raises £ 6.1m
Feb 12, 2009Forth Photonics, a spin-off company of the Foundation for Research & Technology Hellas (FORTH), raised £ 6.1m in order to intensify the marketing of DySIS in the UK and Europe.